Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. BETR
10. DIS

Go back to Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
(NASDAQ: TSHA) Delayed: 5.02 -0.14 (2.71%)
Previous Close $5.16    52 Week High $ 
Open $5.16    52 Week Low $ 
Day High $5.28    P/E N/A 
Day Low $4.96    EPS $ 
Volume 4,314,900       

(NASDAQ: TSHA) Delayed: 5.02 -0.14 (2.71%)
Previous Close $5.16    52 Week High $ 
Open $5.16    52 Week Low $ 
Day High $5.28    P/E N/A 
Day Low $4.96    EPS $ 
Volume 4,314,900